# Pilot Study for the Evaluation of the Safety and Performance of the RenaSense System in Hospitalized Acute Decompensated Heart Failure Patients

> **NCT02324400** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Nephera Ltd.** · enrollment: 36 (estimated)

## Conditions studied

- Heart Decompensation
- Heart Failure, Congestive
- Renal Insufficiency

## Interventions

- **DEVICE:** RenaSense Stimulation
- **DEVICE:** RenaSense Sham Control

## Key facts

- **NCT ID:** NCT02324400
- **Lead sponsor:** Nephera Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-01
- **Primary completion:** 2016-01
- **Final completion:** —
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2014-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02324400

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02324400, "Pilot Study for the Evaluation of the Safety and Performance of the RenaSense System in Hospitalized Acute Decompensated Heart Failure Patients". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT02324400. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*